Role of p53 in the Regulation of Cellular Senescence
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Induction and initiation of cellular growth control and senescence via p53 or P16INK4A pathways. Various internal or external stress factors trigger the DNA-damage response (DDR) pathway, which in turn activates the p53 and/or the p16INK4A pathways. p16INK4A inactivates Cdk4/6, results in accumulation of phosphorylated pRb, stops the regulation of E2F transcription factors, and drives cell cycle arrest or senescence. These stressors also trigger DNA damage (cellular responses to such damages are regulated by either ATM-Chk2 or ATR-Chk1 pathways) and transactivate p53 and p21CIP1. Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].](https://figures.cochat.ai/paper-figures/73d1c8e4b31243a49a8fdf24b567946a/role-of-p53-in-the-regulation-of-cellular-senescence-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb,19,20,21”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
In the citing paper
“The p16INK4A/Rb pathway also plays a critical role in senescence. CDK4/6 are inactivated by p16INK4A, promoting the accumulation of phosphorylated Rb and the inactivation of E2F transcription, which induces senescence.66”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [66]
In the citing paper
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.85”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence is defined as a cell state characterized by prolonged and generally irreversible cell-cycle arrest [14] and the acquisition of different phenotypic alterations, including morphological changes, chromatin remodeling, metabolic reprogramming, and secretion of pro-inflammatory factors or SASP (senesce…”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“This impressive number is a reflection of the many—sometimes alternative—roles p53 can play; in fact, several of these genes are known to be involved in the regulation of metabolism, autophagy, DNA damage repair, cell cycle arrest, quiescence, senescence, and apoptosis [35].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, once p16 is highly expressed, downregulation of p53 cannot reverse cell cycle arrest [58].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“They also reported co-localization of IL-8 and senescence markers in human colon adenomas [42].”
Background
Cited by
Items 201–300 of 640
Xiao, Q., Xiang, H., Tian, Y., Huang, J.-L., Li, M., Wang, P.-Q., Lian, K., Yu, P., Xu, M., Zhang, R.-N., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.176485 · Cited by 16
Sadr, S., Hajjafari, A., Rahdar, A., Pandey, S., Jafroodi, P. P., Lotfalizadeh, N., Soroushianfar, M., Kavasebi, S. S., Kharaba, Z. J., Fathi‐karkan, S., et al. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100238 · Cited by 43
Urbani, C., Mattiello, A., Ferri, G., Raggi, F., Russo, D., Marconcini, G., Cappellani, D., Manetti, L., Marcocci, C., Cardarelli, F., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111090 · Cited by 15
Eleftheriadis, T., Pissas, G., Filippidis, G., Liakopoulos, V., & Stefanidis, I. (2021) · Biomolecules · doi:10.3390/biom11101522 · Cited by 16
“This cell-cycle inhibitor is considered responsible for maintaining the cell in the senescent state [34,35].”
BackgroundUzhachenko, R. V., Shimamoto, A., Chirwa, S., Ivanov, S. V., Ivanova, A. V., & Shanker, A. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00434-9 · Cited by 15
“A role of p53 in senescence is evident from its effect on cell cycle arrest usually mediated by up-regulation of p21, an inhibitor of cyclindependent kinases CDK1, CDK2, and CDK4/6 required for the G1/S transition [120, 121].”
BackgroundNanomaterials for enhanced X‐ray‐triggered cancer therapy: Progress and prospects
Chen, Y., Shangguan, S., Lin, Z., Zeng, X., Chan, S. Y., Qin, X., & Yan, S. (2024) · BMEMat · doi:10.1002/bmm2.12122 · Cited by 16
Li, H., Zhang, J., Shi, Y., Wang, H., Yang, R., Wu, S., Li, Y., Yang, X., Liu, Q., & Sun, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06733-7 · Cited by 26
“The frequency of TP53 mutations was higher in the high-MSRS group, which is consistent with previous reports that TP53 is involved in cell cycle arrest and tumor suppression [65].”
Novel thiazolidine derivatives as potent selective pro-apoptotic agents
Hafez, D. E., Hafez, E., Eddiasty, I., Shih, S., Chien, L.-C., Hong, Y.-J., Lin, H., Keeton, A. B., Piazza, G. A., Abdel‐Halim, M., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105143 · Cited by 16
Multi-Omics Interpretation of Anti-Aging Mechanisms for ω-3 Fatty Acids
Xie, S., Li, H., Jiang, J., Quan, Y., & Zhang, H. (2021) · Genes · doi:10.3390/genes12111691 · Cited by 16
“When activated in response to DNA damage, it causes cell growth to stop, allowing DNA repair to take place, or it causes cellular senescence or apoptosis, preserving genome integrity [22].”
BackgroundLin, B., Xu, D., Wu, S., Qi, S., Xu, Y., Liu, X., Zhang, X., & Chen, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.754554 · Cited by 14
“Aging is a progressive, physiological impairment involving various organs and tissues, which can lead to normal cell regulatory dysfunction; can affect nervous system, respiratory system, immune system and other systems; and is a risk factor for many chronic diseases, such as cancers, cardiovascular diseases, and neur…”
BackgroundHan, H., Hu, S., Hu, Y., Liu, D., Zhou, J., Liu, X., Ma, X., & Dong, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1140916 · Cited by 15
He, M., & Borlak, J. T. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00373-5 · Cited by 15
“Senescence results in pathophysiological changes of the microenvironment, and there is growing evidence for a central role of p53 in directing cellular senescence programs [259].”
BackgroundRossi, C., Venturin, M., Gubała, J., Frasca, A., Corsini, A., Battaglia, C., & Bellosta, S. (2023) · Biomedicines · doi:10.3390/biomedicines11123228 · Cited by 16
Xu, M., Xia, Z.-Y., Sun, J., Liu, C., An, Y., Xu, J., Zhang, S.-H., Zhong, X., Zeng, N., Ma, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395047 · Cited by 16
“Inhibiting the interaction between p53 and its negative regulator MDM4 can rejuvenate p53 activity in melanoma cells, enhancing tumor cell suppression and chemotherapy sensitivity (175).”
Yan, Z., Zhang, L., Kang, Y., Liu, S., Li, X., Li, L., Rui, K., Xiao, M., & Xie, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1424644 · Cited by 20
Anton, P. E., Rutt, L. N., Capper, C., Orlicky, D. J., & McCullough, R. L. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.08.012 · Cited by 18
Zebrafish Models for Skeletal Muscle Senescence: Lessons from Cell Cultures and Rodent Models
Ichii, S., Matsuoka, I., Okazaki, F., & Shimada, Y. (2022) · Molecules · doi:10.3390/molecules27238625 · Cited by 15
“This cyclic arrest is thought to be executed by the activation of p53/p21cip1 and p16INK4a/Rb, particularly in early senescence, and p53/p21cip1 and p16 INK4a/Rb activation in later stages [21,22].”
BackgroundLoss of Dystroglycan Drives Cellular Senescence via Defective Mitosis-Mediated Genomic Instability
Jiménez-Gutiérrez, G. E., Mondragón-González, R., Soto-Ponce, L. A., Gómez-Monsivais, W. L., García‐Aguirre, I., Pacheco-Rivera, R., Suárez‐Sánchez, R., Brancaccio, A., Magaña, J. J., Perlingeiro, R. C. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144961 · Cited by 15
“p53 plays a pivotal role for senescence induction; the DNA damage response activates ataxia telangiectasia (ATM) and Rad3-related (ATR) kinases, which in turn activate the p53/p21 axis by phosphorylation of both p53 and its ubiquitin ligase Mdm2, leading to the stabilization of p53 levels [51].”
BackgroundElucidating the Effects of Curcumin against Influenza Using In Silico and In Vitro Approaches
Kim, M., Choi, H., Kim, S., Kang, L., & Kim, Y. B. (2021) · Pharmaceuticals · doi:10.3390/ph14090880 · Cited by 15
Cellular senescence in human liver under normal aging and cancer
Karpova, A., Li, X., Peng, C.-W., Gallant, K. L., Rapp, D. R., Alligood, D. M., Houston, A. J., Park, A., Targino da Costa, A. L. N., Chou, W.-H., et al. (2026) · Cell Genomics · doi:10.1016/j.xgen.2025.101133 · Cited by 13
“17,18 Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb, 19–21 with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
Khan, A., Alzahrani, H. A., Felemban, S. G., Algarni, A. S., Alenezi, A. B. S., Kamal, M., Rehman, Z. U., Asdaq, S. M. B., Ahmed, N., Alharbi, B., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10226-x · Cited by 16
“The permanent halt in cell division is the main hallmark of cellular senescence (Mijit et al. 2020).”
Mitochondria in cell senescence: A Friend or Foe?
Chen, Q., Young, L. H., & Barsotti, R. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.019 · Cited by 15
Chen, C., Chen, X., Zhang, Y., Zhang, Q., & Shi, H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1605085 · Cited by 25
Molecular Mechanisms of Cellular Senescence in Age-Related Endometrial Dysfunction
Kobayashi, H., Umetani, M., Nishio, M., Shigetomi, H., Imanaka, S., & Hashimoto, H. (2025) · Cells · doi:10.3390/cells14120858 · Cited by 17
“Activation of p53 has been reported to regulate SASP expression via mTOR inhibition, thereby suppressing the secretion of inflammatory cytokines [36–38] (Figure 1 ➀ ).”
Lee, H. J., Kim, S. R., Jung, Y., & Han, J. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-89220-5 · Cited by 12
Yang, Y., Mihajlovic, M., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Masereeuw, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.791612 · Cited by 18
“pivotal in determining the fate of the cells, implying that the p53/p21 pathway is key in the initiation of senescence (Mijit et al., 2020).”
BackgroundTsai, P.-H., Chen, L.-Z., Tseng, K.-F., Chen, F.-Y., & Shen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10040854 · Cited by 12
“DNA damage responds to a rapid increase in p53 levels and the subsequent inhibition of cell growth [27].”
BackgroundImmunomodulation in age‐related disorders and nanotechnology interventions
Chintapula, U. K., Chikate, T., Sahoo, D., Kieu, A., Guerrero-Rodriguez, I. D., Nguyen, K. T., & Trott, D. W. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1840 · Cited by 18
Lee, H., Kim, S.-Y., Lee, S.-W., Kwak, S., Li, H., Piao, R., Park, H.-Y., Choi, S., & Jeong, T. (2022) · Life · doi:10.3390/life12122106 · Cited by 17
“Under conditions such as UV irradiation and oxidative stress, p53 plays a critical role in the cell cycle arrest of senescent cells [48].”
BackgroundEncoding and Decoding of p53 Dynamics in Cellular Response to Stresses
Wang, P., Wang, H., Gao, X., Zhu, H.-X., Zhang, X., Liu, F., & Wang, W. (2023) · Cells · doi:10.3390/cells12030490 · Cited by 14
“Although the regulation of senescence is less well understood, it should be tightly associated with activation of the p53/p21cip pathway and the p16INK4a/pRB pathway [86].”
BackgroundNIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04232-1 · Cited by 16
“As the activation of the P21 signaling network involves P53 whereas P27 signaling does not [41, 42], we examined the actions of NIPSNAP1 in HCT116 cells lacking P53 expression (P53−/−).”
BackgroundLi, Q., Huang, K., Ma, T., Lu, S., Tang, S., Wu, M., Yang, H., & Zhong, J. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09704-8 · Cited by 16
“The activation of these factors is the indication of cellular senescence [13].”
BackgroundChen, B. H., Lu, X. Q., Liang, X. H., & Wang, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-43411-4 · Cited by 13
“This was associated with increased expression of p16 INK4A and p53, key signaling mediators of the cellular senescence pathways 22 , as determined by immunoblot analysis.”
Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence
Fan, Z., Tong, Y., Yang, Z., Wang, S., Huang, T., Yang, D., Ni, Q., Zhang, M., Li, D., Yang, M., et al. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112359 · Cited by 14
“P53 interacts with antiapoptotic Bcl-XL and pro-apoptotic Bcl-2 family proteins, resulting in the release of pro-apoptotic effector bax/bak (Mijit et al., 2020).”
BackgroundCellular senescence in acute kidney injury: Target and opportunity
Li, T., Yang, K., Gao, W., Peng, F., & Zou, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149744 · Cited by 14
MDM2 accelerated renal senescence via ubiquitination and degradation of HDAC1
Xiang, H., Qian, Y., Zeng, J., Xu, Z.-Y., Zhang, H.-Z., Huang, J., Song, A., Xiong, J., & Zhang, C. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01294-9 · Cited by 16
“The association of p53, a central player in cell cycle regulation and recognized marker of cellular senescence, with MDM2 is unclear [11, 26 – 29].”
Lee, M. K., Woo, S. R., Noh, J. K., Min, S., Kong, M., Lee, Y. C., Ko, S., & Eun, Y. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0738 · Cited by 14
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer
Shoemaker, R., Huang, M.-F., Wu, Y., Huang, C., & Lee, D. (2024) · NAR Cancer · doi:10.1093/narcan/zcae037 · Cited by 11
Autophagy in the Cellular Consequences of Tobacco Smoking: Insights into Senescence
Akhtari, M., Jalalvand, M., Sadr, M., & Sharifi, H. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70065 · Cited by 13
“After the induction of senescence, however, p53 levels decrease, while p16 levels remain stable [59].”
Promthep, K., Nopparat, C., Mukda, S., Pannengpetch, S., Wisomka, P., Chantadul, V., Phanchana, M., & Panmanee, J. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.08.015 · Cited by 13
Chen, L., Zhang, L., Jin, G., Liu, Y., Guo, N., Sun, H., Jiang, Y., Zhang, X., He, G., Lv, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112984 · Cited by 14
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
Brown, D. W., Beatty, P. H., & Lewis, J. D. (2022) · Cancers · doi:10.3390/cancers14215176 · Cited by 13
“As mentioned previously, p53 facilitates the expression of p21, which functions as a CDK inhibitor, therefore halting cell cycle progression [67].”
BackgroundDNA damage-dependent mechanisms of ionizing radiation-induced cellular senescence
Guan, J., Li, T., Ma, F., Wang, N., Zhang, H., Li, J., Li, J., Xu, C., & Liu, Q. (2025) · PeerJ · doi:10.7717/peerj.20087 · Cited by 13
“…DNA damage typically results in cellular senescence via two tumor suppressor pathways: the p53—p21 CIP1 axis and p16 INK4a —Rb pathway ( Mijit et al., 2020 ). p21 CIP1 plays dual roles by initially inducing transient G2/M arrest through CDK1/2 inhibition, followed by permanent growth…”
Alam, M. T., Mansoor, M. A. M., Ashiqueali, S., Golusiński, P., Golusińska-Kardach, E., Strzelczyk, J. K., Rubiś, B., Golusiński, W., & Masternak, M. M. (2025) · Cancers · doi:10.3390/cancers17244024 · Cited by 17
“DNA damage, a strong senescence inducer, triggers the DNA damage response (DDR) involving ATM, CHK1 and CHK2 [29]. p53, which transcriptionally regulates genes involved in cell cycle arrest and apoptosis, is phosphorylated and activated by these kinases [30,31].”
The role of DNA damage in neural stem cells ageing
Zhong, Y., Wang, G., Yang, S., Zhang, Y., & Wang, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31187 · Cited by 13
“In addition, problematic proteins can be degraded by promoting autophagy through the p53 pathway (Mijit et al., 2020; Paull, 2021).”
BackgroundRole of DNA damage response in cyclophosphamide‐induced premature ovarian failure in mice
Song, Y., Guo, Z., Song, L., Ma, J., Ma, Y., Shang, L., Meng, Y., Fan, Z., Hao, M., & Zhao, J. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16004 · Cited by 11
“After 72 h of treatment, the positive cell rates of β -gal, γ H2AX, and pATM significantly increased, and the differences were statistically significant at all four doses compared with the control group (Figure 8b) (Supplementary File – 9).”
InfluentialRoles of lncRNAs related to the p53 network in breast cancer progression
Song, J., Cui, Q., & Gao, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453807 · Cited by 10
“4) induce cellular senescence in response to oncogenic stress or extensive DNA damage (31).”
BackgroundMolefi, T., Mabonga, L., Hull, R., Mwazha, A., Sebitloane, M., & Dlamini, Z. (2025) · Cells · doi:10.3390/cells14050382 · Cited by 13
Ficai, S., Papait, A., Magatti, M., Masserdotti, A., Gasik, M. I., Silini, A. R., & Parolini, O. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02620-8 · Cited by 14
The roles of mutant p53 in reprogramming and inflammation in breast cancers
Kummar, S., Fellous, M., & Levine, A. J. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01549-w · Cited by 17
Reyaz, A., Qadri, S. S., Javaid, D., Ganie, S. Y., & Reshi, M. S. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100845 · Cited by 17
The emerging role of cellular senescence in complications of COVID-19
Mohiuddin, M., & Kasahara, K. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100399 · Cited by 11
“Therefore, inhibition of the p53/p21 and p16/Rb pathways represents a promising target for the elimination of cellular senescence [73,74].”
Koons, B., Anderson, M. R., Smith, P. J., Greenland, J. R., & Singer, J. P. (2022) · Current Transplantation Reports · doi:10.1007/s40472-022-00365-2 · Cited by 13
Targeted delivery strategy: A beneficial partner for emerging senotherapy
Zhang, Q., Li, S., Chen, F., Zeng, R., & Tong, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113737 · Cited by 15
Mukem, S., Sayoh, I., Maungchanburi, S., & Thongbuakaew, T. (2023) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2023/6641347 · Cited by 19
“Phosphorylation of p53 has been shown to be critical for telomeric stress-induced cellular senescence and is closely linked to DNA double-stranded breaks (DSBs) and DNA damage response (DDR) activation [63].”
BackgroundSesamol Alleviates Sarcopenia via Activating AKT/mTOR/FoxO1 Signal Pathway in Aged Obese Mice
Yang, J., Wang, Z., Xie, Y., Tang, Y., Fu, Y., Xu, Z., Chen, J., & Qin, H. (2024) · Plant Foods for Human Nutrition · doi:10.1007/s11130-024-01199-2 · Cited by 11
“The onset of cellular senescence is associated with p53 and p16 [15, 16].”
Effect of Selected Antioxidants on the In Vitro Aging of Human Fibroblasts
Bartosz, G., Pieńkowska, N., & Sadowska‐Bartosz, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031529 · Cited by 11
Richter, R. P., Odum, J. D., Margaroli, C., Cardenas, J. C., Zheng, L., Tripathi, K. K., Wang, Z., Arnold, K., Sanderson, R. D., Liu, J., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1390794 · Cited by 13
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential
Goyal, A., Afzal, M., Khan, N. H., Goyal, K., Srinivasamurthy, S. K., Gupta, G., Kumar, K., Ali, H., Rana, M., Wong, L. S., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.03.007 · Cited by 12
“RNAi targeting ribosomal stress regulators stabilize p53 and induce senescence, highlighting the interconnected nature of p53 regulation and cellular homeostasis [21].”
Wu, J., Zhang, L., Zhao, Z., Liu, Y., Li, Z., Feng, X., Zhang, L., Yao, X., Du, J., Chen, L., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102783 · Cited by 10
Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
Meshrkey, F., Ibrahim, S. Y., Bagchi, R. A., & Richardson, W. J. (2025) · Cells · doi:10.3390/cells14181471 · Cited by 12
“In cardiac fibroblasts, p53 activation contributes to cellular senescence and the senescence-associated secretory phenotype (SASP), which includes the secretion of pro-inflammatory cytokines and pro-fibrotic factors [37,117].”
Liu, W., Chuang, H., Chou, C., Lee, Y., Chiu, Y.-J., Wang, Y., & Chiu, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5696686 · Cited by 15
“The p53 [6], p16, and p21 pathways [7] were related to cellular senescence, including fi brosis accompanied by senescence, senescence-related proteins, and SASP-related in fl ammation (Figures 3(a) – 3(f) and Figure 6(d)).”
Basic and translational research on carbon-ion radiobiology.
Sai, S., Koto, M., & Yamada, S. (2023) · PubMed Central · Cited by 15
Ghislanzoni, S., Kang, J. W., Bresci, A., Masella, A., Kobayashi-Kirschvink, K. J., Polli, D., Bongarzone, I., & So, P. T. C. (2023) · Biosensors · doi:10.3390/bios13110973 · Cited by 15
“Their unresponsiveness to treatment has been mainly attributed to the proneness of tumor cells with normal p53 to avoid cell death by undergoing senescence [4,5], a dormant but metabolically active state.”
BackgroundInfectious viruses and neurodegenerative diseases: The mitochondrial defect hypothesis
Jiang, T., Zhu, K., Kang, G., Wu, G., Wang, L., & Tan, Y. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2565 · Cited by 12
“51 Cellular senescence is also characterised by the secretion of a group of cytokines and chemokines by constitutively active NF ‐ kB, termed the senescence ‐ associated secretory phenotype (SASP).”
Partial recovery of senescence in circulating follicular helper T cells after Dasatinib treatment
Talepoor, A. G., Khosropanah, S., & Doroudchi, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107465 · Cited by 10
Disordered regions mediate the interaction of p53 and MRE11
Usluer, S., Galhuber, M., Khanna, Y., Bourgeois, B., Spreitzer, E., Michenthaler, H., Prokesch, A., & Madl, T. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119654 · Cited by 9
Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention
Zamkova, M. A., Александровна, П. Н., Tatarskiy, V. V., & Shtil, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s000629792301008x · Cited by 10
“Activation of these mechanisms occurs in response to DNA damage caused by antitumor treatment [12, 13].”
BackgroundRusu, B., Kukreja, B., Wu, T., Dan, S. J., Feng, M. Y., & Kalish, B. T. (2023) · eNeuro · doi:10.1523/eneuro.0147-23.2023 · Cited by 10
“GSEA analysis of Ts65Dn OPCs also revealed an enrichment for metabolic regulation by p53, a key TF whose upregulation induces growth arrest, apoptosis, and cellular senescence (Mijit et al., 2020).”
BackgroundZhen, X., Sun, Y., Lin, H., Huang, Y., Liu, T., Li, Y., & Peng, H. (2023) · PeerJ · doi:10.7717/peerj.16301 · Cited by 8
Pang, Y., Hu, H., Xu, K., Cao, T., Wang, Z., Nie, J., Zheng, H., Luo, H., Wang, F., Xiong, C., et al. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.5.36 · Cited by 13
“12 NAD + is an essential cofactor for the nonredox NAD + -dependent enzyme SIRT1.”
BackgroundHe, S., Shen, Z., Zhang, R., Liu, P., Li, X., Deng, Q., Zhang, Y., Wang, A., Dou, X., Guo, S., et al. (2025) · Small Structures · doi:10.1002/sstr.202400592 · Cited by 9
Nanoplastics: An emerging environmental concern in age-related diseases
Shiwakoti, S., Dhakal, B., Ok, Y., Gong, D.-S., Ko, J.-Y., Kim, P.-G., & Oak, M. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126972 · Cited by 11
The dual guardians of cellular stability: exploring nesprin and lamin in senescence
Zhou, Z., Qin, Q., Dong, C., Liu, Y., Cao, C., & Teng, L. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08087-w · Cited by 12
“In response to these stress signals, p53 is activated through several mechanisms, including the phosphorylation and stabilization of kinases, leading to the expression of cyclin-dependent kinase inhibitors (CDKIs), such as p21 CIP1 [21, 22].”
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
“TP53 mediates cell growth arrest through a variety of effectors, leading to a series of aging phenotypes (e.g., DNA damage, telomere dysfunction, SASP 39 ) that cause alveolar stem cell regeneration disorders 40 , 41 and promote aging and fibrosis.”
Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology
Zhang, Z., Fang, J., Sun, D., Zheng, Y., Liu, X., Li, H., Hu, Y., Liu, Y., Zhang, M., Liu, W., et al. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6987677 · Cited by 10
“In addition, p53 regulates the expression of a large number of target genes involved in cell cycle arrest, DNA repair, and aging [78].”
BackgroundHaghi‐Aminjan, H., Baeeri, M., Khalid, M., Rahimifard, M., Mahdizadeh, E., Shayesteh, M. R. H., & Abdollahi, M. R. (2021) · Journal of Cluster Science · doi:10.1007/s10876-021-02152-y · Cited by 11
Muscle-specific programmed cell death 5 deletion attenuates cardiac aging
Naz, A., Zhang, S., An, L. K., Song, Z., Zi, Z., Wu, J., Lai, S., Mazhar, H., Xu, M., Chen, Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.142 · Cited by 10
Early differential responses elicited by BRAFV600E in adult mouse models
Bosso, G., Lanuza-Gracia, P., Piñeiro‐Hermida, S., Yılmaz, M., Serrano, R., & Blasco, M. A. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04597-z · Cited by 11
“BRAF expression in vivo triggers an early hyperplastic growth which culminates in a proliferative arrest known as oncogene-induced senescence (OIS) [9, 11, 15], which is driven by p53/p21 and retinoblastoma protein (Rb)/p16 pathways [16, 17].”
BackgroundImmunity, stem cells, and aging
Devaraj, E., Anbalagan, M., Ileng Kumaran, R., & Bhaskaran, N. (2021) · Stem Cells and Aging · doi:10.1016/b978-0-12-820071-1.00006-2 · Cited by 8
Effects of IGFBP3 knockdown on human endometrial mesenchymal stromal cells stress-induced senescence
Ushakov, R. E., Aksenov, N., Pugovkina, N. A., & Burova, E. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.07.046 · Cited by 8
Targeting mitochondrial dysfunction to salvage cellular senescence for managing neurodegeneration
Sharma, K., Sarkar, J., Trisal, A., Ghosh, R., Dixit, A., & Singh, A. K. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.016 · Cited by 8
Long, L., Tang, X., Wang, Y., Gu, J., Xiong, J., Luo, H., Lv, H., Zhou, F., Cao, K., & Lin, S. (2024) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/0113862073273675231114112804 · Cited by 9
Feng, W.-J., Mou, J., Liao, P.-P., Zhou, J., Zhang, N., Hu, T., Wang, S., Zhang, S.-Y., & Mao, Y. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01534-y · Cited by 10
“Previous investigations have shown that advances in geron-tology underscore the importance of cellular senescence in promoting aging (Lin and Kerkelä, 2020; Mijit et al., 2020).”
Cathepsin L induces cellular senescence by upregulating CUX1 and p16INK4a
Wu, Y., Jiang, D., Liu, Q., Yan, S., Liu, X., Wu, T., Sun, W., & Li, G. (2024) · Aging · doi:10.18632/aging.205955 · Cited by 11
“…(GWAS) functional studies on the aging-related CDKN2A/B locus [12], we recently demonstrated that CUX1 is an activator of p16 INK4a , regulating p16 INK4a -dependent cellular senescence via its binding to an atherosclerosis-associated functional SNP (fSNP) rs1537371 on the CDKN2A/B locus [13].”
BackgroundHuang, Y., Hesting, L. L., & Calvi, B. R. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011387 · Cited by 8
“The p53 tumor suppressor is also known to play a major role in the senescent response to a variety of stresses in flies and mammals [75,77].”
Lin, M., Wong, T., & Lin, C. (2024) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/phpp.13005 · Cited by 8
“For example, Kuilman et al. demonstrated that in inflammatory conditions, IL-6 activity is crucial for both initiating and maintaining senescence in human dermal fibroblasts that overexpress BRAF [24].”
Hayrapetyan, L., Roth, S. M., Quintin, A., Hovhannisyan, L., Medo, M., Riedo, R., Ott, J. G., Albers, J., Aebersold, D. M., Zimmer, Y., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0794 · Cited by 12
“As p53 triggers apoptosis and controls the balance between activation of prosenescent and proapoptotic pathways (24), we assessed the induction of apoptosis ( Fig.”
Ali, H. M., Said, M. A., Allam, S., Abdel‐Aziz, H. A., & Abou‐Seri, S. M. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.118053 · Cited by 11
Xiang, H., Yan, C., Lei, Y., Lai, N., Zhang, P., Jiang, K., Zhao, W., Yang, H., Cui, W., & Li, Y. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202506677 · Cited by 9
Centipeda minima active components and mechanisms in lung cancer
Gao, C., Pan, H., Ma, F., Zhang, Z., Zhao, Z., Song, J., Li, W., & Fan, X. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03915-y · Cited by 13
“TP53 has been implicated in a number of fundamental biological processes including DNA repair, cell-cycle arrest, apoptosis, autophagy, senescence, metabolism, and aging [47–50].”
BackgroundDemeule, M., Currie, J.-C., Charfi, C., Zgheib, A., Cousineau, I., Lullier, V., Béliveau, R., Marsolais, C., & Annabi, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355945 · Cited by 12
Sfera, A., Imran, H., Sfera, D. O., Anton, J., Kozlakidis, Z., & Hazan, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115904 · Cited by 10
“As p53, an SCZ risk gene, also promotes cellular senescence, it likely connects microbial translocation to severe mental illness [22,23].”
BackgroundA Lombard Variety of Sweet Pepper Regulating Senescence and Proliferation: The Voghera Pepper
Luca, F. D., Gola, F., Azzalin, A., Casali, C., Gaiaschi, L., Milanesi, G., Vicini, R., Rossi, P., & Bottone, M. G. (2024) · Nutrients · doi:10.3390/nu16111681 · Cited by 10
“The activation of p21 and p53 pathways plays a key role in regulating senescence, and prolonged overexpression of any of these components is sufficient to lead to senescence [39,40].”
BackgroundImplication of integrin α2β1 in senescence of SK-Mel-147 human melanoma cells
Kozlova, N. I., Morozevich, G. E., & Berman, A. E. (2021) · Aging · doi:10.18632/aging.203309 · Cited by 9
Multi-omics evaluation of SARS-CoV-2 infected mouse lungs reveals dynamics of host responses
Wang, Z. N., Yang, X. S., Sun, J., Zhao, J., Zhong, N., & Tang, X. X. (2022) · iScience · doi:10.1016/j.isci.2022.103967 · Cited by 7
“2016). p53 signaling is a classic pathway regulatingcellcycleandcellularsenescence,triggeredbyvariousstimuliincludingDNAdamage,inflammation storm and oxidative stress (Mijit et al., 2020).”
Melatonin protects against nonylphenol caused pancreatic β-cells damage through MDM2-P53-P21 axis
Tao, S., Yang, Y., Fan, Y., Chu, K., Sun, J., Wu, Q., Wang, A., Wan, J., & Tian, H. (2022) · Toxicology Research · doi:10.1093/toxres/tfac016 · Cited by 10
Sanagawa, A., Hotta, Y., Sezaki, R., Tomita, N., Kataoka, T., Furukawa‐Hibi, Y., & Kimura, K. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00322 · Cited by 9
The Multifaceted Roles of Lamins in Lung Cancer and DNA Damage Response
Janetzko, J., Oeck, S., & Schramm, A. R. (2023) · Cancers · doi:10.3390/cancers15235501 · Cited by 10
“Another crucial factor that mediates proper DDR is the tumor suppressor p53 encoded by the TP53 gene (reviewed in [48]).”
Background
Metadata
- Authors
- Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A.
- Affiliations
- University of Siena (IT)
- Temple University (US)
- University of L'Aquila (IT)
- Corresponding author
- Giordano, Antonio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-08
- Volume
- 10
- Issue
- 3
- Pages
- 420
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7175209
- OpenAlex
- W3010215457
- Cited by
- 639
- References
- 128
- Citations by year
- 2026: 100 · 2025: 142 · 2024: 126 · 2023: 96 · 2022: 92 · 2021: 64 · 2020: 17
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- TUScholarShare (Temple University) (submittedVersion, cc-by)
- UniTERAMO Research Catalog (University of Teramo) (submittedVersion, other-oa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Funders
- H2020 Marie Skłodowska-Curie Actions (713714)
- Commonwealth of Pennsylvania, Department of Health (290228/13650)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, DNA damage response, cell cycle arrest, apoptosis, genome stability, aging, antitumor immunity, senescence-associated secretory phenotype, inflammatory cytokines, tumor microenvironment, tissue dysfunction
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Tumor Suppressor Protein p53, Cellular Senescence, Cell Cycle Checkpoints, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.